Kennedy Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Kennedy Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-117,820	Closed	-$4.86M	–	780
2015 Q2	$4.86M	Sell	117,820 -202,869	-63%	-$7.27M	0.09%	403
2015 Q1	$11.3M	Sell	320,689 -166,015	-34%	-$5.62M	0.2%	161
2014 Q4	$15.6M	Sell	486,704 -20,742	-4%	-$600K	0.29%	78
2014 Q3	$14.2M	Buy	507,446 +2,689	+0.5%	+$81.9K	0.28%	86
2014 Q2	$15.3M	Buy	504,757 +64,175	+15%	+$1.77M	0.28%	99
2014 Q1	$12.2M	Buy	440,582 +313,441	+247%	+$8.2M	0.23%	140
2013 Q4	$3.25M	Buy	+127,141	New	+$3.92M	0.06%	465
2013 Q3	–	Sell	-61,233	Closed	-$1.76M	–	797
2013 Q2	$1.76M	Buy	+61,233	New	+$1.69M	0.04%	555

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Kennedy Capital Management's BRLI Position: Q3 2015 in Review

Kennedy Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 117,820 shares — an estimated $4.86M sold.

Kennedy Capital Management first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $15.6M in Q4 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Kennedy Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Kennedy Capital Management sold 117,820 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.86M.
Kennedy Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Kennedy Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $15.6M in Q4 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Kennedy Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.